INTRODUCTION
For many years, diverse groups fiom nearly the entire political spectrum, such as environmentalists, the government, and business interests, have argued that the process of developing and issuing regulations should be reformed. With the change in the political makeup of Congress after the November 1994 elections, regulatory reform moved to the front of the agenda of the 104th Congress. Increased use of cost-benefit analysis in regulatory decision making was considered by Congress, both as part of separate legislation and as a requirement in the reauthorization of several major environmental statutes. The Small Business Regulatory Enforcement Fairness Act Q3.R 3 136), which was signed into law in March 1996, gave Congress regulation-specific review authority before implementation of all regulations. Congress now has the power to disapprove significant regulations by enactment of a joint resolution. The Unfbnded Mandates Act (S. l), signed into law in March 1995, requires federal regulatory agencies to conduct cost-benefit analyses of many new regulations. Other legislation considered but not passed by Congress in the spring of 1995 would have allowed-cost-benefit analysis performed in support of proposed regulatory actions to be chaIlenged in court or by petition to the reguiator. Cost-benefit analysis is fast becoming an important issue in the regulatory arena.
A cost-benefit analysis is a usekl way of organizing a comparison of the favorable and unfavorable impacts of proposed policies on society. Most economists feel that cost-benefit analysis should be used to help decision makers understand the implications of their choice. Even when information on benefits, costs, or both is highly uncertain (as is often the case with environmental regulations), cost-benefit analysis should play an important role in informing the decision making process ( Arrow et al. 1996) .
Since 1981, two Executive Orders have required that federal regulatory agencies perform a cost-benefit analysis before promulgation of a significant regulation. A regulation is defined as significant if it meets any one of four criteria set forth in the Executive Orders. The criterion that most commonly triggers ''signifi~ant~~ status is that the regulation must have an annual impact on the economy of $100 million or more. The first Executive Order (E.O.) requiring cost-benefit analysis was E.O. 12291, which was issued in 1981. W i t h a change in the presidential administration in 1993, a new Executive Order, E.O. 12866, which was issued in September 1993, overrode the previous order.
A major difference between the two orders is in the way they spec* how the regulatory agency should choose the preffened regulatory approach or alternative. E.O. 12866 specifies that the selected regulatory approach should "msudmize net benefits to society (including potential economic, environmental, public health and safety, and other advantages; distributional impacts; and equity)." In contrast, E.O. 12291 specified that the selected regulatory approach's potential benefits to society should "outweigh" its costs, aRer recognizing that not all costs and benefits can be described in monetary or even qualitative terms. However, the statute governing the regulation could override this selection criterion if the statute requires another regulatory approach. 
OVERVIEW OF COST-BENEFIT ANALYSIS

Purpose of Cost-Benefit Analysis
In the public sector, cost-benefit analysis is often used to assist in social decision making, including regulatory decisions. Its objective is to facilitate more efficient allocation of society's resources. A good cost-benefit methodology systematically identifies and measures the benefits and costs of a number of possible alternatives that could be used to achieve the goals of a project or program. Measuring these benefits and costs means not only q u a n w g them but also assigning them a dollar value to the greatest extent possible. Attaching a monetary value to an impact (which is commonly known as monetizing) attempts to show the cost of the impact on society or how much society should be willing to pay to avoid the projected impact. For example, the term "value of We" is often used in the literature. Akhough this term has been very controversial and somewhat misleading, it is used by economists to try to measure the price people are willing to pay for small changes in the probability of reducing different kinds of health and safety risks (Hahn 1996) .
Because regulations af€ect the whole society, the total costs and benefits to society should be considered, not just those that apply to the regulated community. One way to compare each dtemative course of action relative to the basehe or status quo is to find the net benefit, which can be defined as the difference between the monetized benefits and costs. Other ways to compare costs and benefits are discussed in Section 2.2.5. However, major regulatory decisions need not be bound by the strict cost-benefit test of choosing the alternative that has the greatest monetary net benefit to society. Many benefits may be qualified and even quantified but not monetized. Care should be taken to assure that monetized factors do not dominate important factors that are not monetized. In addition, other factors, such as equity within and across generations and distributional effects, may be important and should be considered in the decision-making process.
Components of Cost-Benefit Analysis
In recent years, the theoretical basis of cost-benefit analysis has become well-established and agreed upon by economists. However, implementing aspects of a cost-benefit analysis can be challenging. The five steps of cost-benefit analysis are to (1) develop the baseline and alternatives, (2) identifjl and analyze the benefits of each alternative, (3) identie and analyze costs of each alternative, (4) evaluate the benefits and costs, and (5) compare the benefits and costs. The discussion in the following subsections focuses on important considerations to take into account when performing cost-benefit analysis in support of regulatory decision making.
Development of the Baseline and Alternatives
Identification of a clear baseline is essential because the benefits and costs of each alternative must be measured against a baseline. The baseline should be the best assessment of what is likely to happen without a regulation. Some factors to consider when choosing a baseline are (1) steps the regulated community would take without the regulation, (2) compliance with current regulations, not only fkom the proposing agency but also from other government entities, and (3) compliance with regulations that are not currently in force but have a high likelihood of being enacted. If enactment Page 6 of fbture regulations is uncertain, multiple baselines may be necessary. Consequently, devdoping a baseline can be a very challenging aspect of cost-benefit nmalysis.
A reasonable set of alternatives should be developed next. These alternatives sliould be different and span the range of realistic possibilities. Several approaches could be used to deve1.0~ alternatives, including:
1. Perj4omance-based s&mulzru!s that are writtein in terns of the result to be achieved but do not include detailed requirements for specific actions. For example, such standards could be stated in terms of a percentage reduction in the amount or toxicity of ani emitted pollutant. Such standards could also be set on a plantwide, firmwide, or regional basis rather than for each pollutant source. This approach would allow the regulated parties to choose the most cost-effective way to comply with the regulation.
St &&
based on dzflerent requirements ,for dzflerent segments of the regula,,ted c m m i @ . They might, for example, account fix the size of the f i r m to be regulated. This approach may be taken so a burden is not placed on one segment of the regulated population that is disproportionate to or heavier than the damages that that segment creates.
.
St && based on alternative IeveZs of stringency that consider the relationship between stringency and the size and distribution of benefits and costs among different groups.
4.
Miket-basedsikmabh that use economic incentives to achieve the desired result. These alternatives can include fees, subsidies, penalties, marketable permits, or offsets. Implementing these alternatives may require legislation.
.
Technology-based sfrmdards that specii) the best available control technology or best practicable control technology be used on specific pollution sources. The regulatory agency would determine what technologies meet these requirements.
6. Alrematives ofher than direct reguZation, such as voluntary actions taken by the regulated community.
Alternatives that set a control requirement on each pollutant source (also known as canrnmstnd and control) should not be the only ones Considered. Alternatives that do not meet political, legislative, or budgetary constraints can be screened to determine if'they are appropriate. However, reasons for eliminating alternatives should be clearly stated. Furthermore, although a statute may limit the final selection of a regulatory approach, the cost-benefit analysis should study otlher alternatives to show the consequences caused by statutoiy constraints (Office of Managernent and Budget [OMB] 1996).
Identification and Analysis of Benefits
Because regulations afEect society as a whole, the analysis should include total social benefits. Benefits are defined as the outputs or results of compliance with a regulation, such as reductions in Page 7 risks to human health and the environment. Sometimes the loss of a benefit can be considered to be either a negative benefit or a cost. For example, banning a product results in the loss of the benefit of using the product, after the mitigating effects of possible substitutes are accounted for. This loss of benefit to society is often viewed by some as a cost. It is important that these impacts be accounted for somewhere in the analysis, but they should be counted only once, as either a benefit or a cost.
Because of the dual way some regulatory impacts can be viewed, the method used to compare costs and benefits later in the cost-benefit analysis is very important. Several methods for comparing costs and benefits are discussed in Section 2.2.5. One method, net present value, minimizes the dificulties that can arise during cost-benefit comparisons because of this dilemma in classifying impacts.
The analysis should also account for potential negative benefits, or risk trade-offs, caused by a regulation. These can include effects on media other than the one regulated (commonly referred to as cross-media effects). For example, the amount of solid waste that is generated may increase when air emissions are being controlled, or a regulation that results in improvements in one area may also result in adverse health, sdety, or environmental effects. These risk trade-offs should then be quantified and monetized.
In quantifjmg benefits, several important items should be considered. First, the most likely fkture chain of events should be used to quantifjr benefits to avoid over-or underestimating them. Neither the worst nor the most favorable case should be used in the baseline benefit estimate. Second, benefits for each alternative should be expressed as incremental values over the baseline and should be over a specific and consistent time period. A typical time period is the life span of capital equipment used to comply with the regulation. Also, health benefits (fatalities and illnesses avoided) that result fiom the use of pollution control equipment during the study period should be considered, even though they may occur many years after the study period. Third, impacts should be quanMed by using methods that have undergone an independent or external peer-review process. If uncertainties exist in quantif$ng impacts, the values should be expressed as a range rather than as one number. Finally, the timing of impacts should be clearly stated and accounted for in the analysis, since an impact may occur many years after exposure to a substance. (This time lag in the onset of a disease or fatality is known as a latency period). Also, benefits should be monetized to the greatest extent possible by using methods that have undergone an independent peer-review process.
Identification and Analysis of Costs
Costs are defined as the value of goods and services lost to society as a result of regulatory compliance. Total social costs should be calculated, not only the costs to the regulated community. Total social costs are composed of direct compliance costs, government regulatory costs, deadweight welfare losses, adjustment costs, and other market costs. Direct compliance costs are those costs affecting the regulated sector, including capital and operation and maintenance (O&M) costs for both existing regulated facilities and new ones that will be added during the study period. Increases in papenvork and monitoring costs caused by the regulation should also be included. Government regulatoq costs include pennitting, monitoring, enforcement, and other related costs expected to be incurred by the government after promulgation of a regulation. Deadweight welfare losses are a Page 8 dollar measure of the difference between the value consumers place on output that is lost because of regulation and the cost of producing such output before the regulation. Adjustment costs are the value of resources that are displaced because of regulation-induced reductions in production and the cost of reallocating those resources. An example is the costs a firm incurs in lay-offs ifprclductilon levels are reduced. However, a regulation may increase resource use in both primary and secondary markets; examples are increased demands for alternative products for pollution control equ'p 1 1 memt or increased O&M requirements. These "negative costs" need to be included but should be counted only once, as either a cost or a benefit. Other market costs arise from adverse effects on product quality, productivity, innovation, and market structure.
Historically, direct compliance costs were considered the major cost component of regulatcuy compliance. However, one study concluded that the cost to society or indirect cost can be either higher or lower by a factor of three or four fiom the arithmetic total of direct compliance expenditures @adla and Koop 1990). Consequently, because there can be a wide variance between direct and indirect costs, it is important to carefully csnside:r and evaluate alI of the indirect costs of a regulatory action.
Productivity has an effect on costs. The effects of c:nvironmental regulation on productivity have been analyzed in a number of studies (Office of Technology Assessment [OTA] 1994) . Virtua,lly all of the studies surveyed in the OTA report found that environmental regulations can contribute to a slowdown in productivity. Total factor productivity relates the outputs (value of the prodlucts the plant or f i r m produces) to all inputs to the firm, including capital, labor, purchased inputs, energy, and raw materials. On the other hand, environmental regulations cani also increase productivity for a number of reasons. First, new production processes develolped to comply with regulations inight be more productive than the older ones (Barbera and McConneU 1990) . Second, regulations may reveal outdated management practices and encourage managers to increase their attention on producti.on processes and work practices.
The most likely fbture chain of events should be used to calculate costs to avoid over-or underestimating them. Costs for each alternative should be expressed as incremental values over the baseline for a specific and consistent time period. Costs should be developed by using standard costestimating techniques as well as by obtaining cost estimates fiom the regulated commtinity. If uncertainties exist in estimating costs, they should be expressed as a range rather than as one number.
Finally, the analysis should account for the timing o f costs incurred over the study period.
Evaluation of Benefits and Costs
As noted in the previous two steps, costs and benefits can occur in different years during the study period. Therefore, to compare benefits and costs, it is not appropriate to simply add the values of benefits and costs accruing over time. The values of filture costs and benefits should be moved backward in time, or discounted, relative to the current year (or othier reference year) to obtain their present values. Discounting takes account of the fact that resources (goods or services) available in a given year are worth more than the identical resources available in a later year. One reason for this change in value is that a resource today is worth more than that same resource a year from now, if the resource is invested so as to produce a return on investment.
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Not only should fiture costs and benefits be discounted, but they should be corrected for any real escalation that may occur in the fbture value when compared with the current value. Real escalation reflects price increases that are independent of inflation and above it. A price change can result from resource depletion, increased demand, technology evolution, safety or environmental requirements, or other causes. Therefore, escalation in the fiture costs of such items as equipment purchases, maintenance, health care costs, etc., should be accounted for before discounting.
The choice of a discount rate is an important and rather contentious issue in cost-benefit analysis. Some economists argue that reductions in future health risks should never be discounted, because discounting may significantly reduce the apparent severiv of fbture health effects and lead to the choice of an inequitable option @PA 1987). For regulatory cost-benefit analysis, however, the discount rate is often specified by a government department and applied to both costs and benefits. The analyst should be carefbl to be consistent in the use of "apparentyy or "real" escalation and "apparentyy or "real" discount rate. In other words, inflation should be either consistently included or consistently excluded in the analysis of costs and benefits.
Another way of calculating the present values of both costs and benefits is to annualize the values. Annuahation is done by first fhding the present value of costs and benefits and then annualizing the value over the project Wetime. This procedure is similar to calculating mortgage payments. A project can then be evaluated by comparing the time stream of annual costs and benefits and determining the net benefits @.e., benefits minus costs) each year. Ifthe stream of benefits is constant over the lifetime of the project, comparing annualized costs to annualiied benefits is analytically equivalent to comparing the present values of costs and benefits. 
Comparison of Benefits and Costs
The final step in cost-benefit analysis is to compare the present value of benefits with the present value of costs for each alternative. Two techniques for making cost-benefit comparisons are the benefit-cost ratio technique and net present value technique. The benefit-cost ratio is the present value of benefits divided by the present value of costs. Ratios with a value greater than 1 .O indicate that the monetized benefits outweigh costs, while ratios less than 1.0 indicate that costs outweigh monetized benefits.
A problem inherent to the benefitast ratio technique is the dual way some regulatory impacts can be viewed (ie., a negative benefit can be considered a positive cost). Consider a case in which a project's cost is $5 and its net benefit is $30. The net benefit is made up of a $40 positive benefit to one affected party and a $10 negative benefit to another affected party. Ifthe net benefit is used to calculate the benefit-cost ratio, the ratio is $30/$5 or 6. If instead, the negative benefit is treated as a cost, the benefitast ratio becomes $40/($5 + $10) or 2.7. In these two cases, although the net benefit would remain unchanged, the benefit-cost ratio could be either 6 or 2.7. Benefit-cost ratios are thus subject to manipulation.
Consequently, the best cost-benefit comparison technique is the net present value technique. The net benefits of each alternative action reIative to the baseline or status quo can be easily determined by computing the difference between the present value of monetized benefits and costs. The net present value is the present value of benefits minus the present value of costs. Using this Page 10 comparison technique avoids manipulation of benefits and costs, because the net present value is always the same regardless of whether a benefit or a cost is considered to be positive or negative. In the earlier example, the net present value is $25 if the $10 is considered a cost or a negative benefit. This technique can also be used if benefits and costs are annualized by simply computing the difference between the annualized benefits and costs. M e r finding and comparing the net present value of all alternatives, the decision mak:er should also consider the benefits that were not monetized before making a choice. Care must be taken to assure that monetized factors do not dominate important Iionmonetized factors in !decision making. There may be factors other than economic benefits and costs the decision maker vvill need to weigh before making the final choice. These factors include equity within and across generations, distribution of effects on important subgroups of the population, and potential for irreversilde consequences (Arrow et al. 1996) .
To deal with uncertainty in parameters, sensitivity studies should also be a part of any costbenefit analysis.. Sensitivity studies help determine how the net present value changes if parameters deviate fi-om their assumed or estimated values. A partial sensitivity analysis, which is most commonly used, focuses on the consequences of alternative assurriptions about key parameters.
When many benefits cannot easily be monetized, the results of the cost-benefit analysis can be presented in the form of a cost-effectiveness (CE) analysis. The CE of a regulatory alternative is calculated by dividing the annualized cost of the alternative by a measure of its effectiveness. That measure can range from pollutant reduction (e.g., tons of pollutant removed) to ultimate improvements in human health or the environment (e.g., number of lives saved). Measuring the CE of alternatives allows the decision maker to estimate how much "bang for the buck" each alt.ernatiive delivers. Furthermore, a CE analysis can be performed whether or not benefits are monetized.
In summary, these steps comprise a cost-benefit analysis. Sources in the economic Literature generally agree on how to estimate costs and benefits, which methods can be used, and the attributes and limitations of alternative methods. However, data, mort: than theory or methods, limit the quality of cost-benefit analyses (Rusin et al. 1996) .
Another major consideration when performing a cost-benefit analysis is consistency. Each analysis should not only use consistent data or values but should also be performed to the same level of thoroughness or completeness. Ifthe same level of completeness cannot be achieved in a. specific cost-benefit analysis, any omission should be clearly stated, as well as the reason for the olmission. Consistency is especially important if a cost-benefit aniilysis is used not only to choose among alternatives of a specific regulation but also to compare the effectiveness of different regulations and environmental programs. The EP A conducts full cost-benefit analyses only for "significant regulatory actions." According to E. O. 12866 (1993) , a regulatory action is considered sigmficant if it meets any one of the following four criteria:
1. Has an annual effect on the economy of $100 million or more or adversely S e c t s in a material way: the economy; a sector of the economy; productivity; competition; jobs; the environment; public health or safety; or state, local, or tribal governments or communities; Cost-benefit analyses prepared by the EPA are supposed to be conducted in a manner consistent with E.O. 12866. To comply with the order, the EPA submits to OMBY for review, the cost-benefit analysis in the form of a report called a regulatory impact analysis (RIA) and a copy of the proposed regulation. In 1983, a guidance document was drafted by the EPA to help each EPA program office perform cost-benefit analyses for significant regulations (EPA 1983) . Each program ofice can alter this guidance as they see fit when developing a cost-benefit analysis for a specific regulation (Pate1 1996; Podar 1996) . None of the three EPA program offices considered in this study has developed formal guidance of its own for preparing cost-benefit analyses required by the Executive Order. Completed lUAs may serve as models for new RIAs (Snyder 1996) .
The EPA continues to use the guidance document as an interim guide for performing costbenefit analyses. Although EPA staff members feel the guidance satisfies the requirements of E.O. 12866, they also feel that a revision is necessary to be more compatible with current views on conducting cost-benefit analyses (Snyder 1996) . Also, thiere is a movement within the EPA to call the document required by E.O. 12866 an "economic analysis," but it will take time before the change is fblly adopted.
Evaluation of the EPA's Cost-Benefit Methodologies
This study reviewed cost-benefit methodologies used by OAR, OSW, and OW in the EPA.
These are the three offices that promulgate regulations that are likely to most affect DOE and the energy industries. Because these offices do not have their o w n fonnal guidance for conducting costbenefit analyses, intexviews were held with staff members to determine how cost-benefit analyses are conducted. Eleven recently published RIAs (and support documents) were reviewed to determine how cost-benefit analyses were performed for specific regulations. A list of the RTAs, costeffectiveness reports, and other documents written to support RIAs that were reviewed for this study is shown in Table 1 .
The review was done to determine the type of data ,that will need to be developed to help the EPA accurately evaluate the costs and benefits of energy technologies it might regulate. It is important to note the differences in the cost-benefit methlodologies found both within and between EPA program offices. Such differences can lead to confiision and preclude consistent comparison of regulations. As EPA examines the relative effectiveness of different regulations and programs, it is important to use consistent cost-benefit analyses.
,
The EPA cost-benefit methodologies were evaluated by comparing them with (1) the g e n d methodology and practices discussed in Section 2 and (2) gtlidance in the EPA and OMB documents. The EPA and OMB guidance documents are s u d e d in Table 2 . Differences and inconsistencies existed not only between the different EPA offices' metholdologies (suggesting that they differ from the OMB and EPA guidance documents) but also between methodologies within an EPA program office. These differences and inconsistencies are discussed in Section 3.3. Because findings are based on only a sample of RIAS produced by EPA, the problenrs found should not be viewed necessarily as being widespread and faund in all EPA RTAS. However, the ffidmgs do illustrate the kinds of problems that can occur in a cost-benefit analysis. This section compares differences and inconsistencies in cost-benefit methodologies used by the three EPA program offices. Differences in four areas are discussed: (1) development of alternatives, (2) analysis of benefits, (3) analysis of costs, and (4) evaluation of benefits and costs. These areas parallel the steps discussed in Section 2 for developing a cost-benefit analysis.
Some program offices noted that differences and inconsistencies may occur because the language of some statutes has been interpreted as not allowing the regulatory decision process to consider certain alternatives, costs, or benefits. Consequently, these items may not be included in the cost-benefit analysis developed by the office. However, the analysis should still address these areas to give decision makers information for judging the consequences of statutory constraints (OMB 1996). Furthermore, omitting these areas from the analysis makes a direct comparison of the effectiveness of various regulations and environmental programs dficult.
Development of Baseline and Alternatives
All three program offices develop alternatives in a similar fashion. An EPA work group is formed to develop the regulation and to conduct all technical and analytical work. The work group is composed of stafffiom the office developing the regulation, other program offices, regional EPA offices, the Enforcement and Compliance Division, and others. All offices develop input for possible regulatory alternatives by meeting with representatives fiom environmental groups, state governments, and one or more regulated industries. It is felt that the OAR leads other offices in outreach activities, primarily because the Clean Air Act was reauthorized in 1990. Since then, OAR has accounted for 60% of the new EPA regulations (Eagles 1996) . More outreach activities can be expected fiom other program offices as statutes are reauthorized. However, the Commission on Risk Assessment and Risk Management remains critical of EPA's outreach activities, stating that most EPA partnerships are with industry groups, not environmental groups (Omenn 1996) . This commission, mandated under the 1990 Amendments to the Clean Air Act, considers issues related to the performance of human health risk assessments and the use of these assessments in regulatory decision making. The Commission seems to advocate that EPA offices include all interested stakeholders when developing regulatory alternatives.
When developing h a l effluent guidelines, the EPA is directed by the Clean Water Act (CWA) to consider only technology-based limits and not to consider impacts on water quality. Because of this statutory constraint, OW does not analyze market-based alternatives in cost-benefit analyses (EPA 1993a). Since the scope of the alternatives considered in the RIA is narrowed because of the statute, OW'S methodology does not strictly adhere to OMB or EPA cost-benefit guidelines.
Although the CWA does not allow the EPA to select a market-based alternative as the final effluent guideline, OMB guidance states that some analysis of these other regulatory alternatives should be performed to determine the effect this constraint has on regulatory efficiency.
In developing a baseline, all offices account for current regulations of their office as well as those of other program offices. The offices stated they may even develop several baselines, depending on the status of state, local, or fixture federal regulations in the approval process (Ballard Page 
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and Luben 1996; Eagles 1996; Pate1 1996). Therefore, baseline development appears to be ;a strong point in all of the program offices' cost-benefit methodobgies.
Analysis of Benefits
There are several differences in the ways in which the three EPA program offices address issues related to monetization of benefits, duration of exposure to contaminants, and risk trade-offs. Both OAR and OW monetize benefits to the extent data are available. OSW, however, does not monetize benefits, such as avoided cancers, even though it does calculate the number of cancers that would be avoided by a given alternative. OSW stated that because the Resource Conservation and Recovery Act (RCRA) is based on risk reduction and does riot allow the regulatory decision process to balance costs and benefits, monetization of avoided caricer deaths is not performed (Ballard and Luben 1996) . Consequently, because of this omission, the net present value of costs and benefits cannot be determined from the results of the cost-benefit analysis, and the methodology does riot adhere to OMB and EPA guidelines. Even though RCRA. does not require monetization of cancer benefits, OSW could provide a better comparison of costs and benefits of each regulatory alternative by monetizing those benefits. This would also allow the office to satis@ the philosophy and piinciples of the E.O.
The introductory section of one RIA recently prepared by OAR (EPA 1995a) noted that the benefits of a proposed regulatory action would be discussed. However, the actual analJysis m7as contained in a separate supporting document that was riot referenced in the original RLA @PA 1995b). According to the EPA, it is not uncommon for the information needed to evaluate the costs and benefits of a proposed rule to be contained in several diiierent documents. EPA staff acknowledge this is an awkward means of communicating information on costs and benefits and hope to take steps to limit this unnecessary confusion. However, publishing separate support documents as part of the overall analysis is not confusing if all documents are clearly referenced.
A review of two RIAS recently developed by OSW revealed inconsistencies in the contamhint exposure durations used in the risk assessment models. In one RIA (EPA 1996) , an exposure duration of 30 years was used, while the other (EPA 1 9 9 5~)~ used an exposure duration of 9 years. Both values came fiom theEqosure F a c t o r s H d s o k (EPA 198s) ). The 30-year value is the 90th percentile @&-end exposure) for residence time in one location, while the 9-year value is the 50th percentile (central-tendency exposure). No justification was given in either RIA for the use of obne value over the other. To improve comparative analyses, the! same vstlues should be used for 'all RIAs unless very spec& conditions dictate using a unique exposure duration. The high-end expoisure can be used for an estimate of a maximally exposed actual person (Commission on Risk Assessment and Risk Management 1996) . Also, the EPA has recently suplported the use of central-tendency values to estimate an average population exposure (EPA 199 1). If time and resources allow, calculations should be made for both exposures to determine sensitivity of results to variations in exposure.
Although this weakness was noted in only one application of the OSW cost-benefit methodology, fkrther reviews should be performed to determine if this inconsisteincy exists in other EPA program offices.
Valuing ecological benefits is an area the program oflices the;mselves believe is deficient. The data for valuing the benefits of nonuse and ecological diversity are lacking (Clark 1996; Eagles 1996) .
Consequently, a complete monetization of benefits cannot be performed. However, the EPA's Science Policy Council has recently convened a social sciences work group to study valuation not only of ecological effects but also noncancer health effects (Risk Policy Report 1996). The valuation of ecological benefits is still in its infancy, but the EPA hopes the work group will make some progress in this area.
Risk trade-offs are addressed in varying degrees by all three program offices. A shortcoming exists in the OSW methodology, since the risks resulting fiom the transportation of hazardous wastes are not addressed in the cost-benefit methodology pallard and Luben 1996). The OSW staff members recognize this shortcoming, for which they have been criticized by OMB. Historically, they have not considered transportation risks, since such risks are not under the purview of RCRA. Because hazardous waste alternatives could involve the extensive use of transportation, it may be valuable to consider transportation risks in the methodology. OSW believes that transportation data exist and that such an analysis would not be difficult to perform (Ballard and Luben 1996) . Although this shortcoming was only noted for the OSW cost-benefit methodology, firther reviews should be done to determine if other EPA program offices neglect some potentially important countervailing risks.
Analysis of Costs
As noted in Section 2, one contributor to the total social cost of a regulatory alternative is the direct compliance cost. To calculate this cost, each EPA office uses models containing extensive industry cost data. Compliance cost estimates are also obtained fiom questionnaires sent directly to regulated industrid facilities and by soliciting information fi-om technology vendors (Pate1 1996). Cost estimates obtained fiom industry are carefidly reviewed to assure accuracy (Ballard and Luben 1996; Eagles 1996) . Additional monitoring and paperwork requirement costs are also factored into the compliance cost. This basic process is consistently practiced by aI1 three EPA offices.
However, estimating the total social cost of a regulation does not appear to be done consistently within EPA. Some of the RIAs reviewed accounted for total social costs, such as changes in consumer and producer surplus, while others included only direct compliance costs. Also, none of the studies appeared to examine the effect of the regulation on productivity. The offices attributed these omissions largely to a lack of data. One RLA studying effluent guidelines in the offshore oil and gas industry @PA 1993a) went so far as to quanti+ the loss in producer surplus (in barrels of oil equivalent) as a result of compliance with an alternative but did not monetize the loss, even though the unit cost (i.e., cost of a barrel of oil) was given in the report. In some cases, a regulation aflFected such a broad range of dissimilar industries that compiling the necessary data would be too costly or time consuming. The offices stated that cost-benefit analyses for regulations a&cting only a single industry or several S i a r industries were more likely to have total social costs calculated. This inconsistency in the application of the methodology cuts across all program offices surveyed.
General equilibrium modeIs can be used to calculate total social costs of a regulation. These models can be difficult and expensive to use, particularly if additional model construction or mod&cation is required. Because of the complexity and cost, regulators are unlikely to make general equilibrium models a routine part of an RIA. However, analysts can often make good approximations Page 18 by using existing data, models, and ranges of assumptions about certain costs and behaviors (Rusii et al. 1996) .
Evaluation of Benefits and Costs
A cost-benefit evaluation consists of estimating the full stream of benefits and costs over the study period and calculating the net present value of this stream. However, there are a number of inconsistencies and shortcomings in the way that EPA progrim offices perform this step in their costbenefit methodologies. First, a fill time stream of costs and benefits is not always shown. One RIA reviewed showed the costs and benefits for only the first and last years of the study period @PA 1993a). Costs and benefits for the intervening years were not shown. Consequently, the net. present value of the alternatives analyzed in this RIA could not be calculated. Hahn (1996) has also observed that the full time stream of costs and benefits is not shown in some RIAs.
Second, in all of the RIAs reviewed, the time stream of costs and benefits is not shown as a single net present value but is annualized over the study period. Annualization is an equivalent technique to net present value, but none of the EPA methodologies considered latency effects when annualizing costs and benefits. For example, if an alternative was shown to avoid 70 deaths over 70 years, this was shown as an average of one death avoided each year. In reality, the first cancer death may not occur for 20-30 years. Consequently, benefits can be overstated when latency is not considered. The effect of latency does not appear to be addressed by any of the EPA offices; hence, none of the methodologies adhere to the OMB and EPA guidance h this area. H a h n (1996) has also observed that latency effects are not considered in most ELIAS.
Use of discount rates is another area in which inconsistlencies occur. All of the offices surveyed stated that they derive discount rates from O m l Circular A-94, Guidelines aPzdl3iscoiunt
Rates for Benefif-cost AnaZysis of Federal Progrm (OM3 1992); however, they appeared to apply them inconsistently in actual practice. OW used one discount rate for costs and a different one for benefits (Patel 1996) , while OAR and OSW used the same discourit rate for both costs and benefits (Ballard and Luben 1996; Eagles 1996) . Although there are valid arguments for using the same discount rate or usig different discount rates for costs and. benefits, all EPA program office:^ should use the same methodology so that consistent comparisons can be made. Also, EPA guidance states that under most circumstances, discounting costs by one rate aiid benefits by another should be avoided (EPA 1983). Inconsistency in the use of discount rates has also been noted by Hahri (1996) .
Finally, an RIA does not undergo an external peer review before being submitted to O h 5 . (An external peer review is done by an agency or organization other than the one doing the study).
The program office writing the RIA is responsible for its content (Snyder 1996) . Although an internal peer review once existed at EPA, it has been dismantled (Hopkins 1996) , and an external peer review process has not been filly established, according to a recent Gove:rnment Accounting Office report (Em 1996). However, in light of legislation considered in the 104th Congress (namely, H.R. 9), which would require external peer review of regulatoiry programs, EPA should consider fiully implementing such a program. Using peer-reviewed methods would add to the quality and credibility of the analysis and allow more consistent comparisons between regulations and programs to be made.
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FINDINGS AND CONCLUSIONS
Summary of Findings
After reviewing RIAs and conducting interviews with EPA program office staff, we conclude that the EPA has established a solid fiamework for performing cost-benefit analyses that support regulatory decision making. For more than 15 years, the EPA has conducted these analyses to comply with E.O. 12291 and E.O. 12866. It has relied upon guidance issued by OMB as well as internal EPA guidance. The investigations conducted to prepare this report have indicated that the EPA has generally put forth a conscientious effort to assure that its cost-benefit analyses use the best data and analytical techniques. However, some differences and inconsistencies exist in the costbenefit methodologies used by the different EPA program offices. Shortcomings in EPA cost-benefit analyses can be grouped into three areas: (1) incomplete execution of the methodology, (2) inconsistent use of standard parameters, and (3) lack of external peer review. These shortcomings and their prevalence across program offices are summarized in Table 3 and discussed below.
Incompieteness of Methodoiogy
Execution of methodologies was found to be incomplete in several areas. First, the development of alternatives was sometimes incomplete. For example, OW did not analyze marketbased alternatives for regulations related to effluent guidelines because the CWA does not allow EPA to select this type of alternative for the final regulation. Second, benefits were sometimes not monetized. For example, OSW did not monetize benefits because RCRA does not allow the regulatory decision process to compare costs and benefits. These examples illustrate how a statute can influence the execution of a methodology. Third, sometimes documents containing supporting analysis for an RIA were not referenced in the RIA For example, although the benefits of a proposed regulation were detailed in a supporting document, that document was not referenced in an OAR RIA.
Also, some of the cost-benefit analyses reviewed failed to calculate total social costs. This inconsistency appeared in d program offices surveyed. Reasons given for not calculating total social costs were either that data were lacking or that CompiIation of the necessary data would be too costly or time-consuming. However, some studies have shown that the indirect costs of a regulation can contribute as much or more to total social costs as the direct compliance cost (Hazdla and Koop 1990 ).
Failure to show the full time stream of costs and benefits is an example of another area in which an analysis was found to be incomplete. This omission was discovered in only one of the eleven RIAs reviewed, so fUrther investigation would be usehl to determine how often it occurs. Also, some methodologies used by each of the program offices studied do not consider latency effects of disease. Consequently, benefits may be overestimated, and the RIA will not adhere to OMB and EPA cost-benefit guidance. Failure to show the full time stream of costs and benefits and failure to consider latency effects of disease were observed by Hahn (1996) in his study of RIAs.
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The valuation of ecological benefits was found to be another problematic area in the EPA cost-benefit analyses reviewed. Paucity of data was the main reason given by the program oflkes for this deficiency. A complete quantification or monetizatiori of benefits cannot always be peirformed when data valuing ecological benefits are lacking. However, the EPA is currently taking steps to develop these data (Risk Policy Report 1996).
Finally, failure to address risk trade-offs is another example of incomplete analysis that was discovered. OSW has not addressed transportation risks in its cost-benefit applications. Although other offices state that they do consider countervailing risks, krther investigation is needed to determine how rigorously this work is performed.
Inconsistent Use of Parameters
Exposure durations have been used inconsistently. Within the OSW, one RIA used an exposure duration at the 90th percentile (or high-end exposure), while another RIA for st similar regulation used an exposure duration corresponding to the 50th percentile. No justification was given for using one value over another. This discrepancy was noted in one of the eleven RIAs reviewed; fbther investigation could determine the extent to which thiis inconsistency occurs throughout EPA. It appears that EPA has not specifled standard practices to ensure the consistent and appropriate selection of exposure levels used in RLAS.
Discount rates have also been used inconsistently. A l l offices state that they refer to OM3 guidance for discount rates, but some use the same &scou.nt rate for both costs and benefits, while others use one rate for costs and another for benefits. The EPA should standardize the use of discount rates across all offices or provide case-by-case justification for using alternative discount rates.
Lack of External Peer Review
The lack of external peer review is one shortcsming that cross-cuts all three program offices. If peer review were conducted regularly, some of the aforementioned shortcomings might be identified and corrected before analyses are published. Although the EPA apparently has a mechanism in place for external peer review, it appears to not be fblly implemented (ENEL 1996) . Implementation of such a program would help solve some of the shortcomings as well a:$ adding consistency and credibility to analyses. Furthermore, judging by the legislation considereld by the 104th Congress (such as S. 343), external peer review may soon be required by law.
Conclusions
In summary, consistency is a major consideration in pexforming a cost-benefit analysis. Consistent data and values should be used, and each analysis should be performed to the same level of thoroughness or completeness. Regulatory reform requires that analyses be performed consistently to ensure that the best decisions about specific regulatory actions are made within and across ]?rogrim offices.
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Recommendations
A number of recommendations can be followed to correct the differences and inconsistencies in EPA cost-benefit methodologies noted in this study. First, incompleteness in executing the methodologies used was partially a result of statutory requirements. Although a change in statutory language would correct this shortcoming, this is not a solution over which EPA has direct control. However, when the final selection of the regulatory approach is limited by the governing statute, OMB guidance recommends that other regulatory options still be analyzed (OMB 1996) . In fact, EPA's own guidance (EPA 1983) recommends that market-oriented regulatory alternatives be analyzed, whether or not they are explicitly authorized in EPA's legislative mandate.
Given the reality of the EPA budget and fkequent court-ordered deadlines to publish rules, performing a thorough analysis of alternatives that cannot be selected for the final rule may be difficult. A possible option would be to address these alternatives in a qualitative fashion and state whether or not the economic efficiency of the regulation would be improved if these alternatives could be considered in the decision-making process. This option would provide decision makers with information on consequences of statutory constraints. It couId also provide the public and legislators with the information they need to effect statutory change.
Second, because some inconsistencies occurred only in some RLAS, a checklist or common report format might be able to correct this problem. Since many new R U s are based on past RIAS, omissions that may have occurred in the previous analyses may continue to occur in the new RIAS.
A checklist would help to remind analysts of aIl the components that should beixluded in the methodology. A checklist is currently used by Australian regulators in developing their regulatory documentation (Hopkins 1996) . Additionally, a common report format would make it easier to i d e n e missing pieces of an analysis and make the analysis easier for stakeholders to understand. The EPA O f f i c e of Pollution Prevention and Toxics has developed a document on guidance for its RIAS (EPA 1993b) that not only specifies the format of the RIA but also details how the cost-benefit methodology should be performed and common key parameters that should be used.
Third, since inconsistencies occurred when common parameters were used, standardization of these parameters would correct this problem. For example, the EPA should standardize the selection of exposure levels used in RIAs and clearly state why a level was chosen. Both high-end and central-tendency exposures can be used to represent s@c segments of the population exposure distribution. EPA should make calculations for both exposures to determine the sensitivity of the results to variations in exposure. Also, because latency effects were not considered in the methodologies, EPA should establish average latency periods for diseases. Standardizing latency periods was done in a recent study of RIAs by H a h (1996).
Finally, more extensive external peer review of HAS is needed. Peer review would help to identify problems early in the process and bring a higher level of consistency to the cost-benefit evaluation process. Consistency of analysis is needed if regulatory reform is to be achieved. The EPA itselfhas advocated an external peer review process and should implement it as soon as possible.
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Strengthening Cost-Benefit Analysis through Industry Involvement
The industry being regulated can provide Sonnation to improve cost-benefit analysis and make the regulatory process less contentious. Although a cost-benefit analysis is the regplator's responsibility, industry is most knowledgeable about the technology or product and can provide valuable support to the regulator. Because inadequate data can impede an agency firom performing a thorough cost-benefit analysis, industry can focus some of its own research to fill in data gaps. Typically, industry comments on RIAs focus on direct compliance costs and less frequently on broader social or indirect costs. Industry can focus more attention and research on broader costbenefit considerations. These can include health or envirommental improvements, losses or gains in consumer and producer surplus, and other indirect costs. These additional considerations should also be monetized to the extent possible.
Industry can offer the regulator comments on risk trade-offs. Risk trade-offs can. include items such as changes in quantities of emissions not addressed by the proposed regulation, changes in the health and safety of workers using the product or technology, changes in impacts on special subgroups of the population, changes in intergenerational impacts, and others. Again, attaching a monetary value to these changes w i l l be beneficial to the cost-benefit analysis.
Industry can also assist by providing consistent data to the regulator. This means providing data in consistent units and using consistent time frames andl exposure level assumptions. Providing information on timing of impacts is also important to calcidate net present value correctly.
Finally, since a cost-benefit analysis developed by the EPA can be based on not only the RIA report but also supporting documents, it is important fbr the regulated industry to review all documents written in support of the proposed regulation.
By focusing on weaknesses in the cost-benefit process and providing information to address these areas, the regulated industry can help make the regulatory process less contentious. One RIA noted benefits would be discussed, but did not provide a reference for the document containing the analysis.
Risks associated with transport of hazardous waste were not considered.
Number of cancer deaths avoided by implementing regulatory alternatives were calculated but not monetized.
Nonuse and ecological diversity benefits are generally not monetized in RIAs because of lack of data.
Some RIAs calculate only direct compliance costs, not other costs to society or the nonregulated community.
Only costs and benefits for first and last year of study time period were shown. 
needed.
Follow OMB guidance more fully. Show M l time stream of cost and benefits.
Use consistent exposure estimates for similar studies. Written guidance may be helpful here. Inconsistent use of key parameter: discount rate Different discount rate was used for costs and benefits.
Failure to consider latency effects of fatalities or illnesses
Cancer fatalities that would be avoided as a result of implementing a regulatory alternative were shown as an average over each year of study.
Latency effects were not considered.
Lack of external peer review of cost-benefit analyses
Each program office is responsible for content of cost-benefit analysis; there is no internal EPA peer review process. Mechanism exists for external peer review but it is not fully implemented.
Follow OMB and EPA guidance more fully. All costs and benefits should be discounted. Discounting should be consistent for both costs and benefits.
Consider latency effects as recommended in OMB guidance. Fatalities may not appear for 20-30 years. Develop standard guidance for latency periods for fatalities and illnesses.
Institute more rigorous peer review of costbenefit analyses.
*These hdings are based upon a sample of 1 1 RlAs produced by EPA as well as interviews with EPA staff. The findings should not necessarily be viewed as widespread problem im all U s . They illustrate. the kirnds of problems that em oww in cost-benefit analysis.
